Immunotherapy for Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome Part 2: Intravenous Immunoglobulins and Apheresis Techniques

Intravenous immunoglobulins (IVIG), plasma exchange and semi-selective immunoadsorption represent important options for the treatment of myasthenic crisis or its exacerbations as well as severe chronic myasthenia gravis. They are therefore indispensable components of a comprehensive treatment concept for myasthenic syndromes and complete individual drug treatment which has been discussed in the preceding part of this review. In this publication, the Advisory Board of the German Myasthenia Society (DMG) discusses the indications, study results, adverse events and complications of IVIG, plasma exchange and immunoadsorption and their importance within the treatment concept.